Fudan Tinnitus Doctor for Tinnitus Management

Starting soon · Not applicable

Conditions studied: Tinnitus

In brief

The goal of this clinical trial is to evaluate whether a conversational artificial intelligence-based digital intervention can improve symptoms in adults with chronic subjective tinnitus. The main questions it aims to answer are: Does the Fudan Tinnitus Doctor (FTD) system reduce tinnitus severity as measured by the Tinnitus Handicap Inventory (THI). Does the FTD system improve sleep quality, anxiety, depression, and overall patient-reported outcomes. Researchers will compare the FTD system to a non-conversational digital education program to determine whether the AI-based intervention provides greater clinical benefits. Participants will: Use either the FTD conversational AI system or a static digital education program for 30 days. Complete standardized questionnaires assessing tinnitus severity, sleep, mood, and overall improvement at baseline, Day 14, and Day 30. Engage with the digital platform for tinnitus self-management.

Key facts

Study ID

NCT07558837

Run by

Eye & ENT Hospital of Fudan University

People needed

256

Starts

2026-05-01

Expected to finish

2027-05-30

Last updated by the study team

2026-05-07

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of subjective tinnitus confirmed by a qualified investigator.
• Tinnitus duration ≥ 3 month prior to screening.
• THI score of ≥ 18
• Aged between 18 and 70 years
• The ability to use a smartphone: Both groups will receive therapeutic support and disease management primarily through a mobile application or web-based platform. This requires functional ability to operate the provided software and willingness to engage with the digital intervention protocol.
• Perceptibility: Tinnitus is present and recognizable by the participant under ordinary daily conditions (not only in quiet environments).
• Compliance and consent: Participant is assessed by the Investigator as able to understand study procedures, voluntarily agrees to participate, is willing to comply with all trial-related requirements, and provides signed informed consent prior to performance of any protocol-specified procedure.

You may not qualify if…

• Acute-phase tinnitus (duration < 3 month or tinnitus secondary to acute otologic events).
• Pulsatile or objective tinnitus.
• Unstable symptoms: Fluctuating tinnitus loudness at screening or baseline.
• Psychiatric contraindication: History or current presence of severe psychiatric disorders (e.g., major depressive disorder with recent suicidality, schizophrenia) that, in the opinion of the Investigator, may interfere with study participation or data validity.
• Testing limitations: Inability to adequately complete tinnitus testing procedures or comply with study assessments.
• Prior therapy exposure: Previous history of sound therapy specifically for tinnitus management.
• Concurrent treatments: Ongoing psychotherapy for conditions such as anxiety or depression, or any other psychological treatment that may interfere with the study endpoints.
• Concurrent trial participation: Active participation in another interventional research study that, in the opinion of the Investigator, could affect tinnitus symptoms or interact with study procedures.
• Investigator judgment: Any condition (medical, surgical, psychiatric, or social) or factor which, in the Investigator's judgment, renders the subject unsuitable for participation, places the patient at higher risk, or may interfere with compliance or scientific validity of the trial.

Where it is running

• Fudan University Eye Ear Nose and Throat Hospital, Otorhinolaryngology Department — Shanghai, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.